key: cord-0835100-6fb83hfp
authors: Behnam, Mira A.M.
title: Protein structural heterogeneity: A hypothesis for the basis of proteolytic recognition by the main protease of SARS-CoV and SARS-CoV-2
date: 2021-01-20
journal: Biochimie
DOI: 10.1016/j.biochi.2021.01.010
sha: e5e68d61adaf08e71f0171b562b3bab470012751
doc_id: 835100
cord_uid: 6fb83hfp

The main protease (M(pro)) of SARS-CoV and SARS-CoV-2 is a key enzyme in viral replication and a promising target for the development of antiviral therapeutics. The understanding of this protein is based on a number of observations derived from earlier x-ray structures, which mostly consider substrates or ligands as the main reason behind modulation of the active site. This lead to the concept of substrate-induced subsite cooperativity as an initial attempt to explain the dual binding specificity of this enzyme in recognizing the cleavage sequences at its N- and C-termini, which are important processing steps in obtaining the mature protease. The presented hypothesis proposes that structural heterogeneity is a property of the enzyme, independent of the presence of a substrate or ligand. Indeed, the analysis of M(pro) structures of SARS-CoV and SARS-CoV-2 reveals a conformational diversity for the catalytically competent state in ligand-free structures. Variation in the binding site appears to result from flexibility at residues lining the S(1) subpocket and segments incorporating methionine 49 and glutamine 189. The structural evidence introduces “structure-based recognition” as a new paradigm in substrate proteolysis by M(pro). In this concept, the binding space in subpockets of the enzyme varies in a non-cooperative manner, causing distinct conformations, which recognize and process different cleavage sites, as the N- and C-termini. Insights into the recognition basis of the protease provide explanation to the ordered processing of cleavage sites. The hypothesis expands the conformational space of the enzyme and consequently opportunities for drug development and repurposing efforts.

The coronavirus main protease (M pro , also called 3CL pro ) is a cysteine protease, which contributes to the processing of the viral polyproteins, derived from the translation of the viral RNA, at 11 cleavage sites. 1 A number of studies suggest that the catalytic activity of M pro is associated mostly with dimer structures through a proximity between the N-terminal residues of one protomer and the S 1 subpocket of the other protomer, mediated by an interaction between Glu166 and Ser1* (Figures S2). The arrangement shapes the S 1 subpocket and maintains the oxyanion loop in a catalytically competent state ( Figure S3 ). 2 Relative to the peptide substrate, the active site is divided into subpockets (S and S'), where residues (P and P') of a substrate or ligand can fit. 3 Among the cleavage sites processed by M pro are its N-and C-termini, which are important for the release of the mature protease. 1 At these two sites, the binding specificity was proposed by x-ray structures to vary depending on substrate-induced subsite cooperativity. 4 The presented study hypothesizes an alternate mechanism, where structural heterogeneity of this protein, rather than the sequence of the substrate, is the main determinant for proteolytic recognition by M pro . To support this hypothesis, and in order to gain an understanding of the interplay between structure and function in this target, an analysis of x-ray structures is carried out and interpreted within the context of in-solution biochemical and structural results of relevance to the proteolytic recognition mechanism. The strategy has been previously applied for the study of conformations of the flaviviral protease, a viral protease from another RNA virus. 5 J o u r n a l P r e -p r o o f Figure 1 : Mapping of residues of the main protease of SARS-CoV-2, which differ from SARS-CoV. Structure 6Y2E is depicted in ribbon form in grey, non-conserved residues are shown in stick form in magenta. Cleavage sequences at the N-and C-termini of the main protease (NSP5) are shown. (Sequence alignment and a complete list of cleavage sites are provided in the Supporting Information, as Figure S1 and Table S1, respectively) 

Computational analysis of protein conformations was conducted as previously described, 2 using UCSF Chimera version 1.13.1. 42 Briefly, structural alignment was performed with the "Match Maker" tool in Chimera using default settings. PDB files with dimeric protein structures were split to individual protomers and each protomer was included in the analysis. Default settings were used for visualization.

SARS-CoV-2 M pro shares 96% sequence similarity with, the more extensively studied, SARS-CoV M pro . This high degree of conservation allows exploring the conformational space using all

x-ray structures from both viruses, with a total of 241 structures deposited in the PDB until June 2020. Catalytic competence is determined based on the orientation of the backbone NH groups for residues 143 and 145 in the oxyanion hole. 11 In-solution structural and biochemical studies of an enzyme often provide more relevant mechanistic insight. For the flaviviral protease, for example, the NMR structures (PDB code:

2M9P and 2M9Q) 43 show distinct conformations compared to those observed in x-ray structures.

However, very few NMR studies were conducted on the main protease of SARS-CoV 44-47 and SARS-CoV-2. 7 For SARS-CoV, the separate C-and N-domains of M pro were deposited with PDB code 2LIZ, or biological magnetic resonance bank (BMRB) codes 17911 and 17251. For SARS-CoV-2, NMR signal assignment for M pro is available under BMRB code 50262. As opposed to other viral proteases, such as the flaviviral protease, 5 NMR studies were not combined to the use of tags (lanthanide tags for pseudocontact shifts or tert-butyl groups for high signal intensity) for the protein or the ligand to increase the technique sensitivity in tracking conformational dynamics. The equilibrium between the monomeric and dimeric forms of M pro is suggested to play a role in the understanding of the catalytic mechanism of this enzyme. 48 However, a high variability in monomer-dimer equilibrium dissociation constants was reported for M pro between different research groups and measurement conditions. 48, 49 In some instances, the values are one or more orders of magnitude higher than the common concentration range (submicromolar to nanomolar) used in biochemical assays, where ligand recognition is noticed and assessed. Advances in NMR and monomer-dimer studies of M pro have been reviewed, 47, 48 J o u r n a l P r e -p r o o f and will be addressed within the proteolytic recognition focus of this work and the outcomes of the performed analysis of crystal structures.

A number of hypotheses govern the understanding of SARS-CoV and SARS-CoV-2 M pro : First, the Glu166-Ser1* interaction is needed to achieve catalytic activity, second, the number of catalytically competent protomers within the dimer structure varies in a pH-dependent manner, 19 and third, depending on the ligand steric demand, binding can trigger via induced-fit a change of the inactive state into active state and a modulation of the protein structure in the binding site. 18, 26, 39 As such, only dimeric structures of M pro that display the Glu166-Ser1* interaction are used as starting point for structure-based design and optimization or repurposing of inhibitors. 2, 9 The presented analysis provides structural insights, which contradict the above mentioned concepts for this enzyme and shows that deposited structures are not identical. The study hypothesizes a more general understanding of the coronavirus M pro based on conformational heterogeneity.

Representative structures with distinct conformations are depicted in Figure 1 : 6Y2E, 6Y2F, 6Y2G, 6M0K, 7BRO for SARS-CoV-2, and 1UK3, 2GT7, 2GTB, 2C3S, 2Q6G, 5B6O, 2VJ1, 4MDS, 2DUC for SARS-CoV. The following points are observed:

A) The flexibility in Gly143 affects the orientation of its backbone NH group, as seen in 1UJ1, 2VJ1 and 2DUC, and hence the switch of the oxyanion loop from inactive to active state. in comparison to 1UK3 or 2VJ1. (Figures 2a and 2b) B) The number of active protomers in a dimer structure is pH-independent. 1UJ1 displays one active protomer in the dimer, while in 2GT7 both protomers are in the active state, despite the fact that both structures are crystallized under the same pH and the same space group, which contradicts earlier hypothesis about the influence of pH on the number of active protomers.

However, pH is reported to induce variation of the conformation of protomers in crystal structures obtained at different pH 19 or temperature. 6 The pH-related structural variations are proposed to be caused by changes in the protonation states of His163 and His172.

C) M pro is catalytically active even in the absence of the Glu166-Ser1* proximity. 2VJ1 depicts a dimer in the absence of the Glu166-Ser1* interaction, where the N-terminus points away from the S 1 subpocket, as in an inactive enzyme, but the oxyanion hole retains catalytic competence in one protomer ( Figure S4 ). The construct used for this structure is a SARS-CoV M pro mutant with a Ser1 deletion, which displays a degree of catalytic activity in biochemical assays. 26 The difference in the orientation of the N-terminus and the oxyanion loop conformation results in a modulation of the space available for ligand binding at the dimer interface and in the vicinity of the catalytic center in 6Y2G vs 2VJ1.

It is thus generally noted that apart from the inactive conformation, different conformational states show catalytic competence for M pro , with respect to the number of active protomers, the conformation for the residues lining the S 1 subpocket, in addition to flexibility in other conserved segments of the protein such residues 45-52 and 189-196. (Figures 2a and 2b 

Substrate-induced subsite cooperativity (Figures 3a and 3b) is suggested between S 2 and S 3 ' based on structures 2Q6G and 5B6O. 4 The phenomenon of subsite cooperativity is known to influence specificity in other proteases. 50 For M pro , when the P 2 leucine of the N-terminus cleavage site binds to S 2 , the S 3 ' subsite is not formed. However, the more bulky P 2 phenylalanine in the C-terminus processing site induces a conformational change in S 2 , forming thus the S 3 ' subsite, where the P 3 ' residue fits. The alternate fitting of the N-and C-termini in the enzyme active site in 2Q6G and 5B6O, respectively, provides an interpretation for the dual specificity in autoprocessing observed biochemically in-solution. The performed structural analysis contradicts this mechanism by identifying conformations of the ligand-free protein J o u r n a l P r e -p r o o f depicting the S 3 ' binding space. (Figures 3c-3f) Variation of the active site in S 2 and S 3 ' does not occur in an exclusively cooperative manner but originates instead from conformational dynamics of the protein at Gln189 and Met49, and the segments incorporating them. This study introduces "structure-based recognition" as a paradigm to understand M pro and hypothesizes that conformational heterogeneity is the main determinant for its proteolytic recognition. In this represent the basis behind the concept of substrate-induced subsite cooperativity between S 2 and S 3 ', while (c-f) oppose this mechanism by showing that variations in the active site occur in the absence of a ligand due to conformational heterogeneity and processing depends on structurebased recognition. The binding spaces in S 2 and S 3 ' does not vary in an exclusively cooperative manner. The solvent accessible surface is colored according to hydrophobicity, where blue is hydrophilic and orange is hydrophobic.

The change in the oxyanion loop (residues 139-143) from inactive to active state between the two protomers of 1UJ1 ( Figure S2 and S4a) shows a backbone RMSD of 3.2 Å and 6.5 Å as For example, the RMSD value for Asn142 is 3.5 Å for the catalytically competent protomers in 2VJ1 and 6Y2E, in comparison to an RMSD of 7.0 Å between the inactive and active protomers in 2U1J. This modestly alters the binding space in the S 1 subpocket, however, a more significant influence on ligand fitting is possible, as discussed previously for the P 3 ' residue in section 4.2.

Structures 1UK3, 1UJ1, or 6Y2E in comparison to 1UK4, 2VJ1, 6Y2F, or 6Y2G show that, contrary to earlier interpretations in the field, the catalytic competence represented by the conformation of the oxyanion loop is independent of the presence of ligands or their steric demand ( Figures S2 and S5 ). As such, there is no steric threshold needed by the compound to target a catalytically competent state of this protein. In the conformational selection model, finetuning of the ligand-protein interactions can involve secondary induced-fit events. For SARS-CoV M pro , inhibitor-induced modulation of the active site beyond the S 1 subpocket is reported for example in 4MDS, however, it appears to originate instead from conformation dynamics of the protein, as observed in the analysis for segments incorporating Gln189 or Met49. (Figures 1) As such, the structural evidence postulates a primary contribution for the conformational selection model 60, 61 in ligand recognition for M pro . The versatility of this mechanism makes it more suitable to depict the conformational and kinetic complexity of biological macromolecules. 61 The catalytic competence of M pro is often mentioned to require dimerization, through a Glu166-Ser1* interaction between the N-terminal residues of one protomer or "N-finger" and the active J o u r n a l P r e -p r o o f site of the other protomer. This is supported by the fact that dimeric M pro displays a much higher trans-cleavage of synthesized substrates in biochemical testing in comparison to the monomeric form. However, this general understanding does not explain a multitude of obtained results that show proteolytic cleavage despite deviation from this criterion. This is demonstrated by mutants of the enzyme that retain dimeric structures but lack catalytic activity and those that exist predominantly as monomers in-solution but still are able to process substrates in biochemical assays. For example, both the E166A mutant and the Ser1 deletion (2VJ1) constructs lack the Glu166-Ser1* interaction, the first is reported as a dimer in-solution, 57 and the second shows catalytic competence. 26 The N214A mutant retains catalytic activity, despite being mostly a monomer in-solution. 45 

Due to their pivotal role in the virus life cycle, viral proteases are generally promising targets for drug discovery, capable of achieving broad-spectrum activity against different viruses. 67 Structural heterogeneity and the conformational selection model have implications on the development of assays for hit identification against viral enzymes and on structure-based design as well as hit to lead optimization of antivirals. The latter takes place by expanding the conformational space in search for inhibitors in order to interfere with distinct or multiple conformational states or stages of activity of SARS-CoV and SARS-CoV-2 M pro . The variation of the binding site allows the accommodation of non-canonical and sterically demanding residues that can extend in adjacent subpockets as S 2 and S 3 ', to modulate the properties of the designed antivirals. A number of studies aiming at targeting SARS-CoV-2 main protease rely on J o u r n a l P r e -p r o o f structure-based strategies whether by virtual screening of compound libraries against an x-ray structure of the M pro or by fine tuning of known inhibitor scaffolds to optimize interactions with the active site of the enzyme. It is important to be aware that the outcome of such screenings and optimization efforts will vary depending on the starting structure used, due to inherent conformational heterogeneity of the enzyme. As such, the recommendation is to consider a conformational ensemble for the protein rather than an individual structure.

The present study introduces structure-based recognition as a new concept in the understanding 

The author declares no competing financial interest. 

Characterization of a human coronavirus (strain 229E) 3C-like proteinase activity

Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors

On the size of the active site in proteases. I. Papain

SARS-CoV 3CL protease cleaves its C-terminal autoprocessing site by novel subsite cooperativity

Conformational selection in the flaviviral NS2B-NS3 protease

Structural plasticity of SARS-CoV-2 3CL Mpro active site cavity revealed by room temperature X-ray crystallography

Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication

Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors

Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease

Structural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug carmofur

The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor

Mechanism of the maturation process of SARS-CoV 3CL protease

Structure of the SARS coronavirus main proteinase as an active C2 crystallographic dimer

Production of authentic SARS-CoV Mpro with enhanced activity: Application as a novel tag-cleavage endopeptidase for protein overproduction

C-terminal domain of SARS-CoV main protease can form a 3D domainswapped dimer

Design, synthesis and crystallographic analysis of nitrile-based broadspectrum peptidomimetic inhibitors for coronavirus 3C-like proteases

Crystal structures of the main peptidase from the SARS coronavirus inhibited by a substrate-like aza-peptide epoxide

Crystal structures reveal an induced-fit binding of a substrate-like azapeptide epoxide to SARS coronavirus main peptidase

pH-dependent conformational flexibility of the SARS-CoV main proteinase (Mpro) dimer: Molecular dynamics simulations and multiple x-ray structure analyses

Three-dimensional domain swapping as a mechanism to lock the active conformation in a super-active octamer of SARS-CoV main protease

Mechanism for controlling the dimer-monomer switch and coupling dimerization to catalysis of the severe acute respiratory syndrome coronavirus 3C-like protease

Structure-based design, synthesis, and evaluation of peptide-mimetic SARS 3CL protease inhibitors

Mutation of Asn28 disrupts the dimerization and enzymatic activity of SARS 3CLpro

Mechanism for controlling the monomer-dimer conversion of SARS coronavirus main protease

Two adjacent mutations on the dimer interface of SARS coronavirus 3C-like protease cause different conformational changes in crystal structure

A structural view of the inactivation of the SARS coronavirus main proteinase by benzotriazole esters

A mechanistic view of enzyme inhibition and peptide hydrolysis in the active site of the SARS-CoV 3C-like peptidase

Design of wide-spectrum inhibitors targeting coronavirus main proteases

Design and synthesis of peptidomimetic severe acute respiratory syndrome chymotrypsin-like protease inhibitors

Synthesis, crystal structure, structure−activity relationships, and antiviral activity of a potent SARS coronavirus 3CL protease inhibitor

Structure-based drug design and structural biology study of novel nonpeptide inhibitors of severe acute respiratory syndrome coronavirus main protease

Substrate specificity profiling and identification of a new class of inhibitor for the major protease of the SARS coronavirus

Structure-based design, synthesis, and biological evaluation of peptidomimetic SARS-CoV 3CLpro inhibitors

Structural basis of mercury-and zinc-conjugated complexes as SARS-CoV 3C-like protease inhibitors

Structural basis of inhibition specificities of 3C and 3C-like proteases by zinc-coordinating and peptidomimetic compounds

Development of broad-spectrum halomethyl ketone inhibitors against coronavirus main protease 3CLpro

Peptide aldehyde inhibitors challenge the substrate specificity of the SARScoronavirus main protease

Discovery, synthesis, and structure-based optimization of a series of N-(tert-Butyl)-2-(N-arylamido)-2-(pyridin-3-yl) acetamides (ML188) as potent noncovalent (benzyl)acetamido)phenyl) carboxamides as severe acute respiratory syndrome coronavirus (SARS-CoV) 3CLpro inhibitors: Identification of ML300 and noncovalent nanomolar inhibitors with an induced-fit binding

Fused-ring structure of decahydroisoquinolin as a novel scaffold for SARS 3CL protease inhibitors

Structures of two coronavirus main proteases: Implications for substrate binding and antiviral drug design

UCSF Chimera-A visualization system for exploratory research and analysis

Inhibitor bound dengue NS2B-NS3pro reveals multiple dynamic binding modes

Dissection study on the severe acute respiratory syndrome 3C-like protease reveals the critical role of the extra domain in dimerization of the enzyme

The catalysis of the SARS 3C-like protease is under extensive regulation by its extra domain

13C and 15N resonance assignments of SARS-CoV main protease N-terminal domain

Structurally-and dynamically-driven allostery of the chymotrypsin-like proteases of SARS, dengue and Zika viruses

Targeting the dimerization of the main protease of coronaviruses: A potential broad-spectrum therapeutic strategy

CoV main proteinase: The monomer−dimer equilibrium dissociation constant

Subsite cooperativity in protease specificity

Enzymatic activity of the SARS coronavirus main proteinase dimer

Enzymatic activity characterization of SARS coronavirus 3C-like protease by fluorescence resonance energy transfer technique

3C-like proteinase from SARS coronavirus catalyzes substrate hydrolysis by a general base mechanism

GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease

Evaluating the 3C-like protease activity of SARS-Coronavirus: Recommendations for standardized assays for drug discovery

Quaternary structure of the severe acute respiratory syndrome (SARS) coronavirus main protease

Mutation of Glu-166 blocks the substrateinduced dimerization of SARS coronavirus main protease

Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus

Peptide-boronic acid inhibitors of flaviviral proteases: Medicinal chemistry and structural biology

The role of dynamic conformational ensembles in biomolecular recognition

Mechanisms of ligand binding

Liberation of SARS-CoV main protease from the viral polyprotein: N-terminal autocleavage does not depend on the mature dimerization mode

Selected-fit versus induced-fit protein binding: Kinetic differences and mutational analysis

Processing of the SARS-CoV pp1a/ab nsp7-10 region

Cleavage of the dengue virus polyprotein at the NS3/NS4A and NS4B/NS5 junctions is mediated by viral protease NS2B-NS3, whereas NS4A/NS4B may be processed by a cellular protease

Targeting intramolecular proteinase NS2B/3 cleavages for trans-dominant inhibition of dengue virus

Broad-spectrum agents for flaviviral infections: dengue, Zika and beyond

Heterogeneity and inaccuracy in protein structures solved by X-ray crystallography

The author acknowledges valuable comments of Prof. C. Klein, Heidelberg University.

MB performed the analysis, interpreted the results, and wrote the manuscript. The author read and approved the final manuscript.